Here is an overview of important key figures for the MEB. This is not a complete reflection of all activities of the MEB.
Medicinal products for human use and marketing authorisations
New applications and authorisations
| 35 | Medicinal products with a new active substance |
| 563 | Dutch DCP RMS procedures |
| 1.311 | New marketing authorisations (including parallel) |
| 12.462 | Variations in existing medicinal product authorisations |
| 14.045 | Total number of authorised medicinal products |
European representation
| 124 | The Netherlands involved as Scientific Advice coordinator (SAWP) |
| 8 | The Netherlands Paediatric Investigation Plan rapporteur (PDCO) |
| 14 | The Netherlands rapporteur authorising orphan drug status (COMP) |
| 15 | The Netherlands CHMP rapporteur or co-rapporteur |
| 14 | The Netherlands involved as PRAC rapporteur |
Veterinary medicinal products
Nieuwe aanvragen en inschrijvingen
| 7 | Medicinal products with a new active substance |
| 15 | Applications DCP RMS procedures |
| 111 | New national marketing authorisations |
| 2.621 | Total number of authorised veterinary medicinal products |
European representation
| 8 | The Netherlands CVMP rapporteur or co-rapporteur |
| 3 | The Netherlands rapporteur or co-rapporteur new Maximum Residue Limits |
Botanicals and homeopathica
| 6 | Authorised herbal medicinal products on the basis of traditional use |
| 54 | Total number of authorised herbal medicinal products on the basis of traditional use (31 december 2017) |
| 2 | Authorised herbal medicinal products on the basis of complete dossier |
| 2.911 | Total number of authorised homeopathic medicinal products |
